{"id":12369,"date":"2024-10-11T22:39:12","date_gmt":"2024-10-11T20:39:12","guid":{"rendered":"https:\/\/valintermed.com\/?p=12369"},"modified":"2024-10-11T22:39:12","modified_gmt":"2024-10-11T20:39:12","slug":"oftalmo-akromelicheskiy-sindrom","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/acromophthalmos-syndrome\/","title":{"rendered":"Ophthalmoacromelic syndrome"},"content":{"rendered":"
<\/div>\n

Ophthalmoacromelic syndrome (OAS) is a rare genetic disorder characterized by multiple developmental abnormalities associated with hypercortisolism and pituitary dysfunction. The disorder affects various aspects of the body, including changes in the endocrine system and neoangiogenesis. OAS is most often diagnosed in males, but its manifestations can vary regardless of gender. The main clinical features of this disorder include acromegaly, vision changes that can lead to blindness, and germatoglyphic abnormalities. There are several genes involved in the disorder, and loss of function of these genes can lead to the clinical manifestations of the syndrome.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n